Modulation of Late Adverse Effects of Curative Radiation Therapy for Cancer

Author(s):  
John Yarnold ◽  
Lone Gothard
2018 ◽  
Vol 18 (02) ◽  
pp. 165-168
Author(s):  
Yutaka Naoi ◽  
Kana Yamada ◽  
Chie Kurokawa ◽  
Hiroaki Kunogi ◽  
Yoshiro Sakamoto ◽  
...  

AbstractAimLate adverse effects following radiation therapy for prostate cancer involve the urinary and lower gastrointestinal tracts, with continuous rectal bleeding being the most serious issue. We focused on late adverse effects, particularly rectal bleeding after volumetric-modulated arc therapy (VMAT), for patients with locally advanced prostate cancer.Materials and MethodsSeventy-three patients with localized prostate cancer were treated with radiation therapy using VMAT with an image-guided radiation therapy system. Patient age at the start of irradiation ranged from 54 to 81 years (median, 71 years). The follow-up period ranged from 23 to 87 months (median, 57 months). The prescribed total irradiation dose was 76 Gy in 38 fractions.ResultsLate rectal bleeding was observed in 14 (19%) patients, with nine (12.3%), four (5.5%), and one (1.4%) being classified as grades 1, 2, and 3, respectively. One grade 3 patient with rectal bleeding had severe diabetes and was administered intravenous warfarin for cardiomyopathy.FindingsVMAT may provide better accuracy and involve fewer time constraints for patients compared with other intensity-modulated radiation therapy (IMRT) methods. The incidence of late rectal bleeding in VMAT is almost equivalent to that of other IMRT methods.


2007 ◽  
Vol 46 (4) ◽  
pp. 504-516 ◽  
Author(s):  
Helgi Birgisson ◽  
Lars Påhlman ◽  
Ulf Gunnarsson ◽  
Bengt Glimelius

Author(s):  
Renée L Mulder ◽  
Elvira C van Dalen ◽  
Dorine Bresters ◽  
Yoon Loke ◽  
Edith Leclercq ◽  
...  

2017 ◽  
Vol 6 (2) ◽  
pp. 9 ◽  
Author(s):  
Karin B. Dieperink ◽  
Lene Sigaard ◽  
Helle Mona Larsen ◽  
Tina Broby Mikkelsen

Many cervical cancer survivors experience late adverse effects, and rehabilitation may alleviate symptoms. This study describes participants’ experiences with late adverse effects in daily living and with experiences of perceived rehabilitation in hospital, municipal, and a residential setting. Twenty-one cervical cancer survivors aged 40-72 years, curatively treated with concomitant radio-chemotherapy, with moderate/severe incontinence and sexual problems, participated in a 5-day residential rehabilitation intervention. Three focus group interviews were conducted and analyzed. Late adverse effects like incontinence, sexual problems, tinnitus and pain severely restricted everyday life. The participants described rehabilitation in hospital settings as fragmented, but several of the participants benefitted from the physical rehabilitation in municipal settings; however, no participants were offered sexual rehabilitation. In the residential setting, they gained a sense of connectedness and confidence in association with peers. More time to reflect and the anonymity gave opportunity to work with sensitive issues e.g. sexuality. Increased knowledge about late adverse effects and tools to alleviate these made the participants prepared to regain command of their lives. In conclusion, incontinence and tinnitus had especially impact on social life and every day activities. The participants benefitted especially from rehabilitation in two settings (municipal and residential). Intensively psychosocial interventions allowed participants to work with underlying problems. Women with sexual and/or incontinence problems favored the residential rehabilitation due to anonymity.


2007 ◽  
Vol 13 (4) ◽  
pp. 187-189 ◽  
Author(s):  
Bernardo Moreira ◽  
Sigride Thomé-Souza ◽  
Kette Valente

Lamotrigine (LTG) is a generally well-tolerated antiepileptic drug with broad-spectrum efficacy in several forms of partial and generalized epilepsy. Adverse effects of lamotrigine are usually associated with introduction and titration. This risk increases in children and in the co-medication with valproate. Herein, we report four patients with late adverse-effects, under the co-medication valproate and LTG, not related to drug introduction or titration. This study demonstrates that late side-effects without apparent etiology in children, adolescents and adults in chronic use of LTG, especially when associated to VPA, led to a diagnostic investigation, sometimes invasive. It must be emphasized that, due to the excellent seizure control, the authors opted for drug decrease instead of drug withdrawal, as previously done. Studies on late adverse effects are scarce, but physicians must be aware of these risks.


2014 ◽  
Vol 67 (11) ◽  
pp. 1604
Author(s):  
Aadil A. Khan ◽  
Martin McLaughlin ◽  
Joan Kyula ◽  
Michelle Wilkinson ◽  
Paul A. Harris ◽  
...  

2021 ◽  
pp. 1-14
Author(s):  
Susanne Haas ◽  
Anette H. Mikkelsen ◽  
Camilla Kronborg ◽  
Birthe T. Oggesen ◽  
Pia Moeller Faaborg ◽  
...  

Urology ◽  
2020 ◽  
Vol 144 ◽  
pp. 214-219
Author(s):  
Daniel Smith ◽  
Jacob Albersheim ◽  
Rachel Moses ◽  
Diana O'Dell ◽  
John Stoffel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document